CNBC, Released on 5/15/23
NIH is enrolling patients in an early stage clinical trial to test a universal flu vaccine based on mRNA technology. The technology is behind Moderna’s and Pfizer’s widely used Covid vaccines.
CNBC, Released on 5/15/23
NIH is enrolling patients in an early stage clinical trial to test a universal flu vaccine based on mRNA technology. The technology is behind Moderna’s and Pfizer’s widely used Covid vaccines.